- Home
- GENI vs CRNX Comparison
GENI vs CRNX Comparison
Compare GENI & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENI
- CRNX
- Stock Information
- Founded
- GENI 2016
- CRNX 2008
- Country
- GENI United Kingdom
- CRNX United States
- Employees
- GENI N/A
- CRNX N/A
- Industry
- GENI Services-Misc. Amusement & Recreation
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- GENI Consumer Discretionary
- CRNX Health Care
- Exchange
- GENI Nasdaq
- CRNX Nasdaq
- Market Cap
- GENI 3.0B
- CRNX 2.8B
- IPO Year
- GENI N/A
- CRNX 2018
- Fundamental
- Price
- GENI $11.61
- CRNX $42.50
- Analyst Decision
- GENI Strong Buy
- CRNX Buy
- Analyst Count
- GENI 17
- CRNX 12
- Target Price
- GENI $13.88
- CRNX $74.45
- AVG Volume (30 Days)
- GENI 5.0M
- CRNX 1.5M
- Earning Date
- GENI 11-04-2025
- CRNX 11-06-2025
- Dividend Yield
- GENI N/A
- CRNX N/A
- EPS Growth
- GENI N/A
- CRNX N/A
- EPS
- GENI N/A
- CRNX N/A
- Revenue
- GENI $558,439,000.00
- CRNX $1,392,000.00
- Revenue This Year
- GENI $28.54
- CRNX $420.79
- Revenue Next Year
- GENI $17.14
- CRNX $993.85
- P/E Ratio
- GENI N/A
- CRNX N/A
- Revenue Growth
- GENI 25.76
- CRNX 0.51
- 52 Week Low
- GENI $6.72
- CRNX $24.10
- 52 Week High
- GENI $13.73
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- GENI 41.10
- CRNX 54.21
- Support Level
- GENI $11.67
- CRNX $41.12
- Resistance Level
- GENI $12.17
- CRNX $44.54
- Average True Range (ATR)
- GENI 0.37
- CRNX 1.91
- MACD
- GENI 0.00
- CRNX -0.37
- Stochastic Oscillator
- GENI 25.94
- CRNX 43.15
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.